- Home
- RLAY vs CNOBP Comparison
RLAY vs CNOBP Comparison
Compare RLAY & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- CNOBP
- Stock Information
- Founded
- RLAY 2015
- CNOBP N/A
- Country
- RLAY United States
- CNOBP United States
- Employees
- RLAY N/A
- CNOBP 493
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- CNOBP Major Banks
- Sector
- RLAY Health Care
- CNOBP Finance
- Exchange
- RLAY Nasdaq
- CNOBP Nasdaq
- Market Cap
- RLAY 576.1M
- CNOBP N/A
- IPO Year
- RLAY 2020
- CNOBP N/A
- Fundamental
- Price
- RLAY $3.60
- CNOBP $23.09
- Analyst Decision
- RLAY Strong Buy
- CNOBP
- Analyst Count
- RLAY 11
- CNOBP 0
- Target Price
- RLAY $18.40
- CNOBP N/A
- AVG Volume (30 Days)
- RLAY 1.6M
- CNOBP N/A
- Earning Date
- RLAY 08-05-2025
- CNOBP N/A
- Dividend Yield
- RLAY N/A
- CNOBP N/A
- EPS Growth
- RLAY N/A
- CNOBP N/A
- EPS
- RLAY N/A
- CNOBP N/A
- Revenue
- RLAY $7,679,000.00
- CNOBP N/A
- Revenue This Year
- RLAY $17.59
- CNOBP N/A
- Revenue Next Year
- RLAY N/A
- CNOBP N/A
- P/E Ratio
- RLAY N/A
- CNOBP N/A
- Revenue Growth
- RLAY N/A
- CNOBP N/A
- 52 Week Low
- RLAY $1.78
- CNOBP N/A
- 52 Week High
- RLAY $10.72
- CNOBP N/A
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- CNOBP 57.87
- Support Level
- RLAY $3.50
- CNOBP $22.86
- Resistance Level
- RLAY $3.86
- CNOBP $23.08
- Average True Range (ATR)
- RLAY 0.18
- CNOBP 0.12
- MACD
- RLAY 0.02
- CNOBP 0.00
- Stochastic Oscillator
- RLAY 65.79
- CNOBP 87.76
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.